ALSI Pharma launches new medication – Citalopram

«ALSI Pharma» CJSC has completed registration in the Ministry of Health of the Russian Federation and obtained permits for the release of the new drug of our company, belonging to the group of antidepressants, namely, citalopram (RU LP-001 955 from 25.12.2012).

Citalopram will be produced by us in the form of film-coated tablets in dosages of 10 mg, 20 mg and 40 mg, there will be 30 tablets in a carton box (3 cellular strip packs containing 10 tablets each).

Цитолопрам
Цитолопрам
Цитолопрам

Today we already produce two drugs from the same group of antidepressants: tricyclic antidepressant Amitriptyline in pill form, and a selective serotonin reuptake inhibitor Fluoxetine in the form of hard capsules. These two medications are already known to doctors at least for a quarter century and are among the most commonly prescribed drugs for the treatment of depressive states. However, Amitriptyline, a classic preparation of tricyclic antidepressants, in spite of its high efficiency and sedative properties, has a relatively high level of side effects. Fluoxetine — historically one of the first selective serotonin reuptake inhibitors (SSRIs), that is the large group of drugs, which most of today’s practicing psychiatrists give preference in treating depression. Drugs from this exact group are the treatment of choice for depression.

Today we already produce two drugs from the same group of antidepressants: tricyclic antidepressant Amitriptyline in pill form, and a selective serotonin reuptake inhibitor Fluoxetine in the form of hard capsules. These two medications are already known to doctors at least for a quarter century and are among the most commonly prescribed drugs for the treatment of depressive states. However, Amitriptyline, a classic preparation of tricyclic antidepressants, in spite of its high efficiency and sedative properties, has a relatively high level of side effects. Fluoxetine — historically one of the first selective serotonin reuptake inhibitors (SSRIs), that is the large group of drugs, which most of today’s practicing psychiatrists give preference in treating depression. Drugs from this exact group are the treatment of choice for depression.